InMed Pharmaceuticals
10 hedge funds and large institutions have $138K invested in InMed Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 10 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$40.6K |
| 2 |
Creative Planning
Overland Park,
Kansas
|
+$35.7K |
| 3 |
Morgan Stanley
New York
|
+$22.7K |
| 4 |
JP Morgan Chase
New York
|
+$21.1K |
| 5 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$6.5K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Bank of America
Charlotte,
North Carolina
| $42K | +$40.6K | +25 | New |
|
|
2
Creative Planning
Overland Park,
Kansas
| $36K | +$35.7K | +22 | New |
|
|
3
Morgan Stanley
New York
| $23K | +$22.7K | +14 | New |
|
|
4
JP Morgan Chase
New York
| $21K | +$21.1K | +13 | New |
|
|
5
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $6K | +$6.5K | +4 | New |
|
6
Osaic Holdings
Scottsdale,
Arizona
| $4K | +$3.25K | +2 | New |
|
|
AWM
7
AllSquare Wealth Management
Albany,
New York
| $2K | +$1.62K | +1 | New |
|
8
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | – | – | – |
|
9
Bank of Montreal
Toronto,
Ontario, Canada
| $1K | +$1.62K | +1 | New |
|
|
FF
10
FourThought Financial
Venice,
Florida
| $1K | +$1.62K | +1 | New |
|
|
FDCDDQ
11
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $943 | +$1.62K | +1 | New |
|
INM Hedge Fund Activity: Q4 2020 in Review
10 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in InMed Pharmaceuticals (INM) for Q4 2020, worth a combined $138K.
Buyers outnumbered sellers: 10 funds opened new INM positions and 0 closed out — a net gain of 10 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Bank of America, opening a new position worth an estimated $40.6K.
- 10 institutional investors held InMed Pharmaceuticals (INM) as of Q4 2020, up from 0 in Q3 2020.
- Funds reported $138K of InMed Pharmaceuticals stock for Q4 2020.
- 10 funds opened new InMed Pharmaceuticals positions in Q4 2020 and 0 closed out, a net change of +10 holders.
- The largest InMed Pharmaceuticals buyer in Q4 2020 was Bank of America, an estimated $40.6K added.
Based on aggregated 13F filings for Q4 2020.